Overall the data suggest that if endogenous tumor-specific T cells are engaged sufficiently in PDA, IL-27 in combination with chronic TCR signaling promotes tumor growth by inducing T cell exhaustion. The gene discussed is IL27; the disease is Patent ductus arteriosus.